Inactive Instrument
BioForce Nanosciences Holdings, Inc. Stock Other OTC
Stocks
BFNH
US09064C2061
Other Specialty Retailers
OTC Markets Traded| Market Cap | 61.73M 53.46M 49.84M 45.84M 86.54M 5.87B 87.5M 586M 230M 2.94B 232M 227M 9.73B | P/E 2024 |
-20.4x | P/E 2025 | -14.9x |
|---|---|---|---|---|---|
| Enterprise Value | 61.83M 53.55M 49.92M 45.91M 86.68M 5.88B 87.64M 587M 230M 2.94B 232M 227M 9.74B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
19.02% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +28.57% |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Kaiser
CEO | Chief Executive Officer | 61 | 17/06/2026 |
Merle Ferguson
PSD | President | 79 | 01/12/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Merle Ferguson
CHM | Chairman | 79 | 08/07/2013 |
Richard Kaiser
BRD | Director/Board Member | 61 | 01/07/2013 |
Scott Mager
BRD | Director/Board Member | - | 15/06/2026 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +28.57% | -.--% | - | - | 61.73M | ||
| +2.69% | +7.52% | +159.85% | - | 1.12B | ||
| +0.31% | +0.09% | -16.51% | +150.27% | 736M | ||
| +0.46% | +2.17% | -47.20% | +212.06% | 539M | ||
| -0.82% | +13.95% | +0.63% | - | 78.48M | ||
| Average | +6.05% | +3.30% | +24.19% | +181.16% | 619.42M | |
| Weighted average by Cap. | +1.64% | +2.18% | +57.40% | +176.38% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -490K -425K -396K -364K -688K -46.63M -695K -4.65M -1.83M -23.33M -1.84M -1.8M -77.28M | -1.29M -1.12M -1.04M -959K -1.81M -123M -1.83M -12.26M -4.81M -61.47M -4.85M -4.75M -204M |
| Net Debt | 273K 237K 221K 203K 383K 25.98M 387K 2.59M 1.02M 13M 1.03M 1M 43.05M | 101K 87.05K 81.14K 74.63K 141K 9.56M 142K 954K 374K 4.78M 377K 369K 15.84M |
Employees
-
Sector
Other Specialty Retailers
















